ICT-based system to predict and prevent falls (iStoppFalls): results from an international multicenter randomized controlled trial.

"Competing interests: The PPA (NeuRA FallScreen) and the not-for-profit iPad applications of the Incidental and Planned Exercise Questionnaire (IPEQ) and Iconographical Falls Efficacy Scale (iconFES) are commercially available through Neuroscience Research Australia. The authors declare that they have no further competing interests. Funding sources did not influence the design or implementation of the study as declared in the acknowledgements."

"The iStoppFalls project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no [287361]. The Australian arm was funded by an Australian National Health and Medical Research Council (NHMRC) EU collaboration grant (#1038210). The content of the manuscript does not represent the opinion of the European Community or NHMRC. The funding sources had no influence in any aspects of this study. Yves J. Gschwind was financially supported by a research grant from the Margarete and Walter Lichtenstein Foundation, Basel, Switzerland. Stephen R. Lord was supported by NHMRC as a Senior Principal Research Fellow. Kim Delbaere was supported by a NHMRC as a Career Development Fellow. The other authors were supported by the European Community Grant Agreement 287361. Competing interests: The PPA (NeuRA FallScreen) and the not-for-profit iPad applications of the Incidental and Planned Exercise Questionnaire (IPEQ) and Iconographical Falls Efficacy Scale (iconFES) are commercially available through Neuroscience Research Australia. The authors declare that they have no further competing interests. Funding sources did not influence the design or implementation of the study as declared in the acknowledgements. Authors’ contributions: Funding for the study was obtained by KD and RW. All authors were involved in the design and conduct of the trial. All authors contributed to writing the manuscript. YG and KD drafted the manuscript. All authors critically revised and approved the final manuscript. The authors declare that the submitted paper, the data, and the results have not been published anywhere before."

"Trial registration Australian New Zealand Clinical Trials Registry Trial ID: ACTRN12614000096651 International Standard Randomised Controlled Trial Number: ISRCTN15932647"